Dichloroisoproterenol

Generic Name: Dichloroisoproterenol

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₁H_₁₅Cl_₂NO

CAS Number: 59-61-0

Unique Ingredient Identifier: U7NOE2K4M2

Background: Dichloroisoproterenol has been used in trials studying the treatment and basic science of Insulin Resistance and Polycystic Ovary Syndrome.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Oral Administration of DCI to Women With PCOS

Phase 2

Terminated

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Placebo
Drug: DCI

First Posted Date: 2007-07-09

Last Posted Date: 2011-11-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 13

Registration Number: NCT00497653

Locations: 🇺🇸
General Clinical Research Center, Richmond, Virginia, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy